Roche, Glaxo Await OK for Easier Osteoporosis Drug (Reuters
Reuters - A new once-monthly osteoporosis pill
could be good news for sufferers of the brittle bone disease
and a profitable new opening for Roche Holding AG and
GlaxoSmithKline Plc, analysts believe.
Read more...
Stumble It!
Tweet This
Bookmark on Delicious
Share on Facebook
Share on MySpace